When back ache means your spine's starting to fuse together
Huw Irranca-Davies, 51, from Ogmore, South Wales, has ankylosing spondylitis, a type of chronic arthritis. (Source: the Mail online | Health)
Source: the Mail online | Health - July 15, 2014 Category: Consumer Health News Source Type: news

Celgene's Phase III POSTURE trial of Otezla fails to meet primary endpoint
US-based biotechnology firm Celgene has reported results from its Phase III POSTURE trial evaluating its oral, selective inhibitor of phosphodiesterase 4 (PDE4) 'Otezla', in patients with active ankylosing spondylitis. (Source: Drug Development Technology)
Source: Drug Development Technology - July 10, 2014 Category: Pharmaceuticals Source Type: news

RheumShorts: Fibromyalgia, Scleroderma, Spondylitis (CME/CE)
(MedPage Today) -- News in rheumatology this week included water therapy for fibromyalgia, Gleevec for the often-lethal interstitial lung disease in scleroderma, and a temporary setback for apremilast in ankylosing spondylitis. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 10, 2014 Category: Primary Care Source Type: news

Bone Changes in Spine Disease Worse With Inflammation (CME/CE)
(MedPage Today) -- High disease activity in ankylosing spondylitis (AS) was associated with radiographic disease progression in the spine, a longitudinal study showed. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 10, 2014 Category: Primary Care Source Type: news

RheumShorts: Triple Therapy, Q Fever, and Etanercept (CME/CE)
(MedPage Today) -- Dutch researchers weighed in this week about triple therapy for rheumatoid arthritis, the dangers of Q fever for patients with RA, and the implications of serum levels of etanercept (Enbrel) for patients with ankylosing spondylitis. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 8, 2014 Category: Geriatrics Source Type: news

Lower Enbrel Dose Cuts Efficacy in Spine Disease
LIVERPOOL (MedPage Today) -- Decreasing the weekly dose of etanercept (Enbrel) from 50 mg to 25 mg among patients with ankylosing spondylitis was less effective than maintaining the standard dose, a researcher reported here. (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - May 1, 2014 Category: Anesthesiology Source Type: news

US Features of the Shoulder in Ankylosing SpondylitisUS Features of the Shoulder in Ankylosing Spondylitis
Learn more on the ultrasound abnormalities in shoulders of patients with ankylosing spondylitis. BMC Musculoskeletal Disorders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 11, 2013 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Systemic Bone Loss Seen in Spine Disease (CME/CE)
(MedPage Today) -- A loss of peripheral bone mineral density accompanied the spinal changes seen in patients with ankylosing spondylitis, a sophisticated imaging study showed. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 7, 2013 Category: Rheumatology Source Type: news

FDA OKs Cimzia for Active Ankylosing SpondylitisFDA OKs Cimzia for Active Ankylosing Spondylitis
UCB Pharma has received a complete response letter on their supplemental application for certolizumab for active axial spondyloarthritis. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 18, 2013 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Certolizumab Pegol Effective for Axial SpondyloarthritisCertolizumab Pegol Effective for Axial Spondyloarthritis
Certolizumab pegol safely reduced signs and symptoms of axial spondyloarthritis (SpA), including ankylosing spondylitis (AS), in the RAPID-axSpA trial. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2013 Category: Consumer Health News Tags: Rheumatology News Source Type: news